Centene Corp (CNC) Issues Strong FY12 Outlook; Reaffirms FY11 Expectations
Get Alerts CNC Hot Sheet
Price: $64.14 --0%
Financial Fact:
Net earnings attributable to Centene Corporation: 145M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net earnings attributable to Centene Corporation: 145M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Centene Corporation (NYSE: CNC) announced today its 2012 financial guidance.
The Health Benefits Ratio and the General and Administrative expense ratio below reflect the reclassification of certain General and Administrative expenses and Medical Costs to reflect the National Association of Insurance Commissioners (NAIC) definitions released earlier this year.
For its 2012 fiscal year, the Company expects:
The Health Benefits Ratio and the General and Administrative expense ratio below reflect the reclassification of certain General and Administrative expenses and Medical Costs to reflect the National Association of Insurance Commissioners (NAIC) definitions released earlier this year.
For its 2012 fiscal year, the Company expects:
- Premium and Service Revenues in the range of $7.2 billion to $7.6 billion. The Street sees revs of $7.19 billion.
- Earnings per diluted share of approximately $2.60 to $2.80.
- Consolidated Health Benefits Ratio of approximately 87.0% to 88.0%.
- Consolidated G&A expense ratio in the range of 9.5% to 10.0%.
- Effective tax rate, excluding non-controlling interest, of approximately 38.5% to 39.0% and diluted shares outstanding of approximately 53.4 million.
- Days in claims payable between 39 and 44.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Bicara Therapeutics (BCAX) Reiterated at Market Outperform by Citizens as Pivotal Trial Advances
- Citi raises Deere price target to $650, keeps Neutral rating
Create E-mail Alert Related Categories
GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share